Results 151 to 160 of about 209,238 (297)
Impact of standardized team‐based care on cardiogenic shock outcomes over time
ESC Heart Failure, EarlyView.This contemporary North American cardiogenic shock (CS) registry aimed to investigate the influence of team‐based care on outcomes over a six‐year period of time following implementation of standardized protocols. Despite a two‐fold increase in the number of CS patients and changes in presentation and management strategies, no differences in in ...Behnam N. Tehrani, Carolyn M. Rosner, Adetokunbo Fadahunsi, Kimberly Barker, Wayne B. Batchelor, Vanessa Blumer, Lindsay Clevenger, Shashank Desai, Michelle Ferri, Evan Franke, Jamie Kennedy, Christopher King, Edward Howard, Iyad Isseh, Seiyon Ben Lee, Aditya Mehta, Mitchell Psotka, Ramesh Singh, Shashank S. Sinha, Matthew W. Sherwood, Daniel Tang, Megan Terek, Alexander G. Truesdell, Ilan Vavilin, Christopher M. O'Connor +24 morewiley +1 more sourceAdaptation of right ventricular function following tricuspid transcatheter edge‐to‐edge repair
ESC Heart Failure, EarlyView.Right ventricular remodelling following tricuspid transcatheter edge‐to‐edge repair. After T‐TEER, most patients either maintain or decrease their RVEF, while only a minority experience an increase. Patients with increased RVEF were associated with TR worsening and worse prognosis.Sara Bombace, Sebastian Rosch, Anne R. Schöber, Maximilian von Roeder, Florian Schlotter, Karl‐Philip Rommel, Recha Blessing, Christian Lücke, Matthias Gutberlet, Anna Sannino, Holger Thiele, Philipp Lurz, Karl‐Patrik Kresoja +12 morewiley +1 more sourceP4397Effect of mild renal failure on admission on short- and long-term outcomes in patients with STEMI undergoing primary PCI [PDF]
, 2018 D Jelic, Dejan Milašinović, Zlatko Mehmedbegović, S Zaharijev, V Zobenica, A Pavlovic, V Dedovic, Vladan Vukčević, Milika Ašanin, Goran Stanković +9 moreopenalex +1 more sourceTherapy gaps for patients with heart failure and reduced kidney function: A prospective cohort study
ESC Heart Failure, EarlyView.In this prospective registry of 1401 heart failure outpatients, patients with eGFR <60 mL/min/1.73m2 had lower achievement of target RASi and MRA doses, with the lowest absolute use in patients with eGFR <30. Beta blockers were consistently prescribed across all heart failure phenotypes and kidney function.Chen Hsiang Ma, Arthur Qi, Luke Gagnon, Kaiming Wang, Chandu Sadasivan, Anukul Ghimire, Matthew Cooper, Somkanya Tungsanga, Bonaventure Oguaju, Ben Vandermeer, Finlay A. McAlister, Aminu K. Bello, Gavin Y. Oudit +12 morewiley +1 more sourceDual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
New England Journal of Medicine, 2017 C. Cannon, Deepak L. Bhatt, J. Oldgren, G. Lip, S. Ellis, Takeshi Kimura, M. Maeng, B. Merkely, U. Zeymer, S. Gropper, M. Nordaby, E. Kleine, Ruth Harper, Jenny Manassie, J. Januzzi, J. T. ten Berg, G. Steg, S. Hohnloser +17 moresemanticscholar +1 more sourceGuideline‐directed medical therapy after revascularization and outcomes in ischaemic cardiomyopathy
ESC Heart Failure, EarlyView.Among patients with ischaemic heart failure undergoing revascularisation, those receiving GDMT had lower unadjusted mortality rates. The combination of GDMT and CABG was associated with the best long‐term outcomes. In real‐world practice, the use of GDMT increased over time, reflecting a growing emphasis on guideline‐based therapy even after ...Carlos Moliner‐Abós, Maria Calvo‐Barceló, Eduard Solé‐Gonzalez, Andrea Borrellas Martín, Paula Fluvià Brugués, Jesus Sánchez Vega, Joan Vime Jubany, Maria Ferré Vallverdú, Manel Taurón Ferrer, Pablo Eduardo Tobias Castillo, Juan Carlos de la Fuente Mancera, Pau Vilardell Rigau, Rosa Vila Olives, Carles Diez López, Antoni Bayés‐Genís, Dabit Arzamendi Aizpurua, Ignacio Ferreira González, Sònia Mirabet Pérez +17 morewiley +1 more sourcePCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
New England Journal of Medicine, 2017 H. Thiele, I. Akin, M. Sandri, G. Fuernau, S. de Waha, R. Meyer‐Saraei, P. Nordbeck, T. Geisler, U. Landmesser, Carsten Skurk, A. Fach, H. Lapp, J. Piek, M. Noc, Tomaz Goslar, S. Felix, L. Maier, J. Stȩpińska, K. Oldroyd, P. Serpytis, G. Montalescot, O. Barthelemy, K. Huber, S. Windecker, S. Savonitto, Patrizia Torremante, C. Vrints, S. Schneider, S. Desch, U. Zeymer +29 moresemanticscholar +1 more sourceIntravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes
European Journal of Heart Failure, EarlyView.Abstract Aims
Intravenous iron has emerged as a guideline‐recommended therapy in patients with heart failure and iron deficiency, but the potential sex‐related differences in efficacy are unknown. We aimed to assess sex‐specific outcomes in the Intravenous Iron in Patients with Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality Mahir Karakas, Tim Friede, Javed Butler, Khawaja M. Talha, Marius Placzek, Thomas Asendorf, Monika Diek, Anna Nosko, Adriane Stas, Stefan Kluge, Dominik Jarczak, Geraldine DeHeer, Meike Rybczynski, Antoni Bayes‐Genis, Michael Böhm, Andrew J.S. Coats, Frank Edelmann, Gerasimos Filippatos, Gerd Hasenfuß, Wilhelm Haverkamp, Mitja Lainscak, Ulf Landmesser, Iain C. Macdougall, Bela Merkely, Burkert M. Pieske, Fausto J Pinto, Tienush Rassaf, Jennifer K. Visser‐Rogers, Giuseppe Rosano, Maurizio Volterrani, Stephan von Haehling, Markus S. Anker, Wolfram Doehner, Hüseyin Ince, Friedrich Koehler, Gianluigi Savarese, Muhammad Shahzeb Khan, Ursula Rauch Kröhnert, Tommaso Gori, Teresa Trenkwalder, Ibrahim Akin, Christina Paitazoglou, Iwona Kobielusz‐Gembala, Luca Kuthi, Norbert Frey, Manuela Licka, Stefan Kääb, Karl‐Ludwig Laugwitz, Piotr Ponikowski, Stefan D. Anker +49 morewiley +1 more source